drugset / Trial / NCT05849922
A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This was a Phase 2 study in adult participants with moderate to severe hidradenitis suppurativa (HS). The purpose of the study was to evaluate the efficacy and safety of SAR442970 compared to placebo.
Timeline
- Start
- 2023-06-06
- Primary completion
- 2024-08-22
- Completion
- 2025-01-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivekimig | Protein / enzyme biologic | 150 mg/ml | — |